Shortly after acquiring Elektrofi to beef up its subcutaneous drug-delivery offerings, Halozyme Therapeutics has struck ...

COLORADO SPRINGS, CO, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- Lahjavida Bio, a biotechnology company ...

In a study published in the Journal of Extracellular Vesicles, scientists from the UF Health Cancer Institute have found a way to make treatment for a notoriously aggressive breast cancer more ...

Add Yahoo as a preferred source to see more of our stories on Google. Many major pharmacies have home delivery services that often cost no more than what you already pay for your medicine. Regular ...

The Surf Bio acquisition comes shortly after Halozyme bought another company with a subcutaneous delivery technology, ...

Optimizing drug delivery to the lymphatic system is essential for effective cancer treatment, as lymph node (LN) metastasis ...

For some common medical conditions, timing is everything when it comes to taking medications. Now, a customizable capsule engineered at UC San Diego could simplify complicated dosing schedules thanks ...

In a merger between two subcutaneous drug delivery companies, Halozyme Therapeutics is paying $750 million in cash to acquire Elektrofi. Aside from the $750 million upfront payment, the deal also ...

Gastroretentive drug delivery systems (GRDDS) represent a sophisticated approach to oral medication by extending the retention time of dosage forms in the stomach. This increased residence time can ...

Drug delivery utilizes various methods and/or carriers to transport therapeutic agents to the tissue, organ, cell, or subcellular organ of interest for release and absorption. Some of the primary ...